Pretraga

Rezultati

Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma (✓) [2016]

Bila, Jelena ; Sretenovic, Aleksandra; Jelicic, Jelena ; Tošić, Nataša ; Glumac, Irena ; Fekete, Marija Dencic; Antić, Darko ; Todorović, Milena ; Marković, Olivera ; Milojevic, Zoran;

Radojković, Milica ; Trajković, Goran ; Puric, Mila; Pavlović, Sonja ; Mihaljević, Biljana ;

Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma [2015]

Bila, Jelena ; Jelicic, Jelena ; Djurasinovic, Vladislava; Vukovic, Vojin; Sretenovic, Aleksandra; Andjelic, Bosko; Antić, Darko ; Todorović, Milena ; Mihaljević, Biljana

Ultra-high-risk prognostic significance of double and triple hit myeloma (✓) [2021]

Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A.

Early Evaluation and Therapy Adjustment in Advanced Stage Hodgkin Lymphoma-The Role of PET/CT (✓) [2019]

Tucović, Aleksandra; Purić, Mila; Milanović, Nenad ; Đorđević, Feđa; Artiko, Vera ; Šobić-Šaranović, Dragana

Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) [2018]

Djordjevic, Fedja R

Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy [2023]

Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S ; Schjesvold, Fredrik; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hajek, Roman; Usenko, Hanna;

Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;

Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy (✓) [2017]

Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Tijanić, Ivan

Generic Imatinib in Chronic Myeloid Leukemia Treatment: Long-Term Follow-up (✓) [2019]

Ćojbašić, Irena ; Mačukanović-Golubović, Lana ; Vučić, Miodrag ; Ćojbašić, Žarko

Assessment of Symptom Burden in Patients with Hematologic Malignancies using Edmonton Symptom Assessment System (ESAS) at the Time of Admission to the Institute for Oncology and Radiology of Serbia (IORS) as a Treatment Tailoring Concept [2019]

Dimitrijevic, Jelena

Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients [2017]

Pavlović, Sonja T. ; Marjanović, Irena M. ; Karan-Đurašević, Teodora Ž. ; Ugrin, Milena M. ; Virijević, Marijana M. ; Tomin, Dragica S. ; Suvajdžić-Vuković, Nada D. ; Tošić, Nataša M. ; Vidović, Ana D.